Verteporfin Photodynamic Therapy of Choroidal Neovascularization in Angioid Streaks

This small series suggests that treatment of CNV secondary to angioid streaks with verteporfin PDT seems to limit visual loss in most patients through the first 12 months of follow-up, particularly in those with subfoveal lesions at baseline.